Researchers are exploring the use of nanorobots to administer clotting drugs directly to brain aneurysms, presenting a novel approach to stroke prevention.
A recent study, primarily involving rabbit subjects, highlights the potential of these microscopic robots, which are considerably smaller than blood cells, to deliver clot-inducing medication precisely to the site of an aneurysm.
Qi Zhou, a research associate specializing in bioinspired engineering at the University of Edinburgh and co-author of the study, emphasized the advantages of these magnetic nanorobots. This method allows for a minimally invasive procedure, avoiding the need for implants and reducing the risks associated with traditional treatments like stents and coils that often require the use of long-term blood thinners.
The nanorobots’ design features a magnetic core wrapped in a special coating that dissolves upon heating, releasing thrombin, a clotting agent. Surgeons can direct the nanorobots to an aneurysm using a magnetic field; then, localized heat prompts the drug release, facilitating clot formation to seal off the aneurysm. This method strategically targets the aneurysm, sparing the surrounding brain vessels from invasive procedures.
In trials conducted on rabbits with artificially induced aneurysms, the nanorobots effectively formed stable clots that sealed the aneurysms without affecting brain blood circulation. The rabbits remained healthy throughout a two-week observation period, confirming the approach’s initial safety and efficacy.
The research team plans to extend testing to larger animals that more closely replicate human anatomy and physiology, refining the magnetic guidance system to enhance the precision of the nanorobots, especially for reaching aneurysms situated deeper within the brain. Although extensive further testing is required, the initial success of these nanorobots offers a promising glimpse into future aneurysm treatment methodologies, potentially transforming how these critical conditions are managed.
